Australia's BCAL Diagnostics launches early detection cancer platform, shares rise

BCAL Diagnostics

19/05/2026 04:50

** BCAL Diagnostics BDX.AX shares rise as much as 24.7% to A$0.096, their highest level since April 2

** Health care co launches national referral infrastructure to support access to its early cancer detection test portfolio and scale commercial distribution

** About 604,582 shares traded so far, 5.1x 30-day

** Stock down 23.8% this year, including day's move

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))